APIs
Sitagliptin phosphate monohydrate
Sitagliptin phosphate monohydrate
Mol. Wt.: 523.3
Vildagliptin
Mol. Wt.: 303.4
274901-16-5
Dapagliflozin
Mol. Wt.: 408.87
Dapagliflozin is mainly used to treat type 2 diabetes. It can also be used to treat heart failure and Chronic Kidney Disease (CKD).
Under Development
Empagliflozin
Mol. Wt.: 450.91
Under Development
Canagliflozin
Mol. Wt.: 444.52
Under Development
Sacubitril-Valsartan
Mol. Wt.: 1916.02
Under Development
Slide For More
Sl. | Product Name | Structure | Molecule details | Cas. No. | Remarks/Uses | Specification | Status |
1 | Sitagliptin phosphate monohydrate |  | M.F.:C16H20F6N5O6P | 654671-77-9 | It is a medications to lower blood sugar levels in adults with type 2 diabetes | IP/USP | Commercial |
2 | Vildagliptin |  | M.F.:C17H25N3O2 | 274901-16-5 | It is used for the treatment of type II diabetes mellitus in adults. | IP | Commercial |
3 | Sacubitril-Valsartan |  | M.F.: C96H120N12Na6O21 | 936623-90-4 | To treat chronic heart failure in adults. | In-house | Commercial |
4 | Empagliflozin |  | M.F.: C23H27ClO7 | 864070-44-0 | Empagliflozin is used to treat type 2 diabetes. | - | Under Development |
5 | Canagliflozin |  | M.F.: C24H25FO5S | 842133-18-0 | It is used to treat type 2 diabetes. It is also used to lower the risk of heart attack and stroke. | - | Under Development |
6 | Dapagliflozin |  | M.F.: C21H25ClO6 | 461432-26-8 | Dapagliflozin is mainly used to treat type 2 diabetes. It can also be used to treat heart failure and Chronic Kidney Disease (CKD). | USP | Under Development |
Sitagliptin phosphate monohydrate
M.F.:C16H20F6N5O6P
Mol. Wt.: 523.3
654671-77-9
It is a medications to lower
blood sugar levels in
adults with type 2 diabetes
Complete
Vildagliptin
M.F.:C17H25N3O2
Mol. Wt.: 303.4
274901-16-5
It is use for the treatment of
type II diabetes mellitus in adults
Complete
Dapagliflozin
M.F.: C21H25ClO6
Mol. Wt.: 408.87
461432-26-8
Dapagliflozin is mainly used to treat type 2 diabetes. It can also be used to treat heart failure and chronic kidney disease (CKD)
API Under Devlopment
Empagliflozin
M.F.: C23H27ClO7
Mol. Wt.: 450.91
864070-44-0
Empagliflozin is used to treat type 2 diabetes
API Under Devlopment
Canagliflozin
M.F.: C24H25FO5S
Mol. Wt.: 444.52
842133-18-0
To treat type 2 diabetes. It is also used to lower the risk of heart attack, stroke.
API Under Devlopment
Sacubitril-Valsartan
M.F.: C96H120N12Na6O21
Mol. Wt.: 1916.02
936623-90-4
To treat chronic heart failure in adults.
API Under Devlopment
Sitagliptin phosphate monohydrate
Mol. Wt.: 523.3
654671-77-9
blood sugar levels in
adults with type 2 diabetes
Complete
Vildagliptin
Mol. Wt.: 303.4
654671-77-9
Complete
Dapagliflozin
Mol. Wt.: 408.87
Under Devlopment
Sacubitril-Valsartan
Mol. Wt.: 1916.02
936623-90-4
Under Devlopment
Canagliflozin
Mol. Wt.: 444.52
842133-18-0
Under Devlopment
Empagliflozin
M.F.: C23H27ClO7
Mol. Wt.: 450.91
864070-44-0
Under Devlopment
